Latest News and Press Releases

Longeveron licenses patented stem cell technology from the University of Miami.

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership TeamWill spearhead clinical...

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in obesity and cardiometabolic research, portfolio strategy development and...

Data published in Obesity journal show enhanced weight loss effect of NT-0796 when combined with semaglutide in preclinical obesity modelObese state completely reversed with 30% weight loss and...

Austin, April 21, 2025 (GLOBE NEWSWIRE) -- According to the latest report by SNS Insider, the Chronic Disease Management Market was valued at USD 4.83 billion in 2023 and is projected to reach USD...

ACTG Presents Findings from REPRIEVE at CROI 2025 Presentations Address Frailty, Inflammation, Asymptomatic Heart Muscle Damage, and Mental Function

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

New York, United States, March 06, 2025 (GLOBE NEWSWIRE) -- A cholesterol test, a lipid panel, or a lipid profile is a blood test used to measure cholesterol levels and other fats in the blood. It...

Belleville, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Allsup, the nation’s leading provider of Social Security Disability Insurance (SSDI) representation services, is highlighting the important...